Serial Number
97251461
Owner
Performance Cell Manufacturing, Inc.Attorney
Paul J. KennedyFirst Use Date
Feb 14, 2022
Filing Date
Feb 3, 2022
Serial #97251461 Trademark
Serial Number: 97251461 • Registration: 7375159
Trademark Classes
Owner Contact Info
12860 Danielson Court, Suite B
Poway, CA 92064
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
February 3, 2022
Registration Date
April 30, 2024
First Use Anywhere
February 14, 2022
First Use in Commerce
February 14, 2022
Published for Opposition
July 4, 2023
Goods & Services
Manufacturing services for others in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals, namely, custom manufacture of pharmaceuticals, chemotherapy drugs and antibiotic medicines by pharmaceutical compounders; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in mammalians, namely, custom manufacture of pharmaceuticals, chemotherapy drugs and antibiotic medicines by pharmaceutical compounders; manufacturing process consulting; Production in the nature of custom manufacture of cell lines for others using lentivirus technology; Production in the nature of custom manufacture of a recombinant or manipulated lentivirus; Production in the nature of custom manufacture of mitochondria, cell lysates, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in mammalians
Providing regulatory compliance and regulatory compliance consultation and advisory services with respect to relevant state and federal law for organizations in the pharmaceutical, biotech, life science, and other government-regulated industries
Research and development in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, research and development in the fields of assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services, namely, research and development in the fields of assaying, and purifying mitochondria, cell lysates, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in mammalians; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; CDMO (Contract Development and Manufacturing Organization) services, namely, pharmaceutical drug development services; material testing; product quality testing; scientific laboratory services; scientific research